Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Nov 26, 2020 10:36am
126 Views
Post# 31978224

RE:RE:RE:RE:RE:RE:RE:RE:RE:Would be great if we break that psychological wall at 0.70$

RE:RE:RE:RE:RE:RE:RE:RE:RE:Would be great if we break that psychological wall at 0.70$

well stated Lithlover, you delay results then come out with adjustments, doesn't look very professional to institutional investors. The hype of Q3 was a couple days ago people saw and moved on.



LithLover wrote: Exactly.  Need more time and more "prove to me" NR and reporting. 

I mean really they had 2 extra days to file to calculate the warrants and they screwed it up.  

If they expect the institutional investors to buy in they cant be making these types of mistakes.  

Tripp needs to close the Offering, provide some real guidance and move on.  No more overpromises and no more delays or mistakes.  Come on guys.


 

capebretongirl wrote:
Kabron wrote: Probably ppl waiting to hear if we sold out and see if Tripp provides a Q4 update? No sure.... this stock is weird.



Its simply investor sentiment - its not on our side at the moment - we need news bigger than this to light the fire.




<< Previous
Bullboard Posts
Next >>